A Japanese pharmaceutical company prevailed Thursday in a Las Vegas case involving two women who claimed the diabetes drug Actos caused them to develop bladder cancer.
A Japanese pharmaceutical company prevailed Thursday in a Las Vegas case involving two women who claimed the diabetes drug Actos caused them to develop bladder cancer.